SGMT logo

SGMT
Sagimet Biosciences Inc

2,001
Mkt Cap
$170.33M
Volume
183,324.00
52W High
$11.41
52W Low
$1.84
PE Ratio
-3.26
SGMT Fundamentals
Price
$5.14
Prev Close
$5.32
Open
$5.31
50D MA
$5.42
Beta
0.00
Avg. Volume
365,397.59
EPS (Annual)
-$1.58
P/B
1.50
Rev/Employee
$0.00
$78.44
Loading...
Loading...
News
all
press releases
Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eleven brokerages that are currently covering the firm...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Sagimet Biosciences (NASDAQ:SGMT) Now Covered by Rodman & Renshaw
Rodman & Renshaw assumed coverage on shares of Sagimet Biosciences in a research report on Thursday. They set a "buy" rating and a $28.00 price objective for the company...
MarketBeat·12d ago
News Placeholder
Sagimet Biosciences (SGMT) Expected to Announce Quarterly Earnings on Monday
Sagimet Biosciences (NASDAQ:SGMT) will be releasing its Q4 2025 earnings on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-sagimet-biosciences-inc-series-a-stock...
MarketBeat·15d ago
News Placeholder
HC Wainwright Has Negative Outlook for SGMT FY2027 Earnings
Sagimet Biosciences Inc. (NASDAQ:SGMT - Free Report) - Analysts at HC Wainwright dropped their FY2027 earnings per share (EPS) estimates for Sagimet Biosciences in a report issued on Wednesday, March...
MarketBeat·22d ago
News Placeholder
Sagimet Biosciences (NASDAQ:SGMT) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen raised Sagimet Biosciences from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·24d ago
News Placeholder
Q1 Earnings Forecast for SGMT Issued By HC Wainwright
Sagimet Biosciences Inc. (NASDAQ:SGMT - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 earnings per share estimates for Sagimet Biosciences in a research report issued on...
MarketBeat·25d ago
News Placeholder
Sagimet Biosciences (NASDAQ:SGMT) Receives Buy Rating from HC Wainwright
HC Wainwright restated a "buy" rating and set a $29.00 price target on shares of Sagimet Biosciences in a research note on Wednesday...
MarketBeat·26d ago
News Placeholder
Sagimet Biosciences (NASDAQ:SGMT) Issues Earnings Results
Sagimet Biosciences (NASDAQ:SGMT - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.30) EPS for the quarter, beating analysts' consensus estimates of...
MarketBeat·27d ago
News Placeholder
Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten analysts that are covering the firm, Marketbeat.com reports. One...
MarketBeat·30d ago
News Placeholder
Sagimet Biosciences (SGMT) Projected to Post Earnings on Wednesday
Sagimet Biosciences (NASDAQ:SGMT) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 11. (View Earnings Report at...
MarketBeat·1mo ago
<
1
2
...
>

Latest SGMT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.